AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
14min chapter
The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)
ACQ2 by Acquired
Understanding GLP-1 Medications for Weight Loss and Diabetes Control
Exploration of lerakotide and semaglutide's impact on energy intake and satiety, focusing on the brain's role in regulating hunger and the reward system. Discussion on GLP-1's role in postprandial processes, its adaptability for pharmacological use, and potential to reach the brain. Insight into the development of medications like semaglutide with longer-lasting effects by enhancing binding to albumin, aiming for improved weight loss and therapy adherence.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode